These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21792296)

  • 1. Five-day regimen of intramuscular or subcutaneous self-administered adrenocorticotropic hormone gel for acute exacerbations of multiple sclerosis: a prospective, randomized, open-label pilot trial.
    Simsarian JP; Saunders C; Smith DM
    Drug Des Devel Ther; 2011; 5():381-9. PubMed ID: 21792296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bio-equivalence of IM and SQ H.P. Acthar Gel.
    Brod SA; Morales MM
    Biomed Pharmacother; 2009 May; 63(4):251-3. PubMed ID: 18848765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative efficacy of intravenous methylprednisolone and ACTH in the treatment of acute relapse in MS.
    Thompson AJ; Kennard C; Swash M; Summers B; Yuill GM; Shepherd DI; Roche S; Perkin GD; Loizou LA; Ferner R
    Neurology; 1989 Jul; 39(7):969-71. PubMed ID: 2544829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience of Using Adrenocorticotropic Hormone in the Treatment of Patients With Acute Neuromyelitis Optica Who Failed Systemic Steroids: A Case Series.
    Berkovich R
    Clin Neuropharmacol; 2020; 43(1):7-14. PubMed ID: 31876792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticosteroids or ACTH for acute exacerbations in multiple sclerosis.
    Filippini G; Brusaferri F; Sibley WA; Citterio A; Ciucci G; Midgard R; Candelise L
    Cochrane Database Syst Rev; 2000; 2000(4):CD001331. PubMed ID: 11034713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute improvement in exacerbating multiple sclerosis produced by intravenous administration of mannitol.
    Stefoski D; Davis FA; Schauf CL
    Ann Neurol; 1985 Oct; 18(4):443-50. PubMed ID: 3000278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-week combination treatment with ACTH + magnesium sulfate versus ACTH monotherapy for infantile spasms: a 24-week, randomized, open-label, follow-up study in China.
    Zou LP; Wang X; Dong CH; Chen CH; Zhao W; Zhao RY
    Clin Ther; 2010 Apr; 32(4):692-700. PubMed ID: 20435238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating refractory dermatomyositis or polymyositis with adrenocorticotropic hormone gel: a retrospective case series.
    Levine T
    Drug Des Devel Ther; 2012; 6():133-9. PubMed ID: 22787386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced diabetic nephropathy with nephrotic range proteinuria: a pilot study of the long-term efficacy of subcutaneous ACTH gel on proteinuria, progression of CKD, and urinary levels of VEGF and MCP-1.
    Tumlin JA; Galphin CM; Rovin BH
    J Diabetes Res; 2013; 2013():489869. PubMed ID: 24159603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of adrenocorticotropic hormone gel in refractory dermatomyositis and polymyositis.
    Aggarwal R; Marder G; Koontz DC; Nandkumar P; Qi Z; Oddis CV
    Ann Rheum Dis; 2018 May; 77(5):720-727. PubMed ID: 29237618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized, Single-Blind, Parallel Clinical Trial on Efficacy of Oral Prednisolone Versus Intramuscular Corticotropin on Immediate and Continued Spasm Control in West Syndrome.
    Wanigasinghe J; Arambepola C; Sri Ranganathan S; Sumanasena S; Attanapola G
    Pediatr Neurol; 2015 Sep; 53(3):193-9. PubMed ID: 26216500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of idiopathic FSGS with adrenocorticotropic hormone gel.
    Hogan J; Bomback AS; Mehta K; Canetta PA; Rao MK; Appel GB; Radhakrishnan J; Lafayette RA
    Clin J Am Soc Nephrol; 2013 Dec; 8(12):2072-81. PubMed ID: 24009220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient adherence to and tolerability of self-administered interferon β-1a using an electronic autoinjection device: a multicentre, open-label, phase IV study.
    Lugaresi A; Florio C; Brescia-Morra V; Cottone S; Bellantonio P; Clerico M; Centonze D; Uccelli A; di Ioia M; De Luca G; Marcellusi A; Paolillo A;
    BMC Neurol; 2012 Mar; 12():7. PubMed ID: 22390218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral ACTH (H.P. Acthar(®)Gel) inhibits IL-1 and IL-17 secretion in humans.
    Brod SA; Bauer V; Hood Z
    Biomed Pharmacother; 2012 Feb; 66(1):36-9. PubMed ID: 22244960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healthcare Costs and Resource Utilization in Patients with Multiple Sclerosis Relapses Treated with H.P. Acthar Gel(®).
    Gold LS; Suh K; Schepman PB; Damal K; Hansen RN
    Adv Ther; 2016 Aug; 33(8):1279-92. PubMed ID: 27312977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous methylprednisolone for multiple sclerosis in relapse.
    Barnes MP; Bateman DE; Cleland PG; Dick DJ; Walls TJ; Newman PK; Saunders M; Tilley PJ
    J Neurol Neurosurg Psychiatry; 1985 Feb; 48(2):157-9. PubMed ID: 2984332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACTON PROLONGATUM® suppresses spasms head to head with Acthar® Gel in the model of infantile spasms.
    Chern CR; Chern CJ; Velíšková J; Velíšek L
    Epilepsy Behav; 2020 Apr; 105():106950. PubMed ID: 32092460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Randomized Trial Evaluating Various Administration Routes of Natalizumab in Multiple Sclerosis.
    Plavina T; Fox EJ; Lucas N; Muralidharan KK; Mikol D
    J Clin Pharmacol; 2016 Oct; 56(10):1254-62. PubMed ID: 26835603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results from a multicenter, randomized, double-blind, placebo-controlled study of repository corticotropin injection for multiple sclerosis relapse that did not adequately respond to corticosteroids.
    Wynn D; Goldstick L; Bauer W; Zhao E; Tarau E; Cohen JA; Robertson D; Miller A
    CNS Neurosci Ther; 2022 Mar; 28(3):364-371. PubMed ID: 34984839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic indications for acute episodes of multiple sclerosis].
    Brochet B
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):988-95. PubMed ID: 11787365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.